Search for: "ELI LILLY & CO."
Results 521 - 540
of 1,009
Sorted by Relevance
|
Sort by Date
8 Apr 2010, 5:21 pm
Eli Lilly & Co. v. [read post]
25 Jun 2011, 4:55 am
See Eli Lilly & Co. v. [read post]
10 Nov 2015, 9:16 am
” Eli Lilly & Co. v. [read post]
20 Jun 2016, 9:10 am
Reg.48697–48698.This inconsistency had been an argument for those supporting the Cuozzo position; Reuters noted:Cuozzo was supported by several industry groups and companies, which urged the justices to take the case.One friend-of-the-court brief filed in the case on behalf of 3M Co, Caterpillar Inc, Eli Lilly and Co and Qualcomm Inc said the patent office reviews and litigation in district court needed to be streamlined for the "proper functioning of… [read post]
16 Jul 2021, 12:53 pm
Eli Lilly & Co., 598 F.3d 1336, 1352 (Fed. [read post]
26 Aug 2021, 12:55 pm
Co., 896 F.3d 1357, 1361 (Fed. [read post]
30 Jan 2013, 1:47 pm
Eli Lilly & Co., 2012 WL 1893551, at *3 (D. [read post]
1 Aug 2016, 4:45 pm
Eli Lilly & Co. v. [read post]
21 Mar 2013, 10:11 am
See In re Eli Lilly, 902 F.2d 943 (Fed. [read post]
18 Aug 2010, 12:19 am
and industrial applicability on 7 October: Eli Lilly & Co v Human Genome Sciences Inc (IPKat) Nuvigil (Armodafinil) – US: Cephalon and Mylan Pharmaceuticals agree to drop two patents from Nuvigil patent suit (Patent Docs) OxyContin (Oxycodone) – Patent infringement complaint filed following a Paragraph IV certification: Purdue Pharma L.P. et al. v. [read post]
6 Oct 2008, 5:00 am
Eli Lilly & Co., No. [read post]
9 Apr 2009, 7:52 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US CAFC clarifies obviousness standard in context of cDNA cloning invention: In re Kubin (Holman's Biotech IP Blog) (Patent Docs) (Hal Wegner) (Philip Brooks' Patent Infringement Updates) (Patently-O) (Patent Docs) Xigris (Drotrecogin alfa) –US: CAFC: Pioneering claims require more expansive written description: Ariad v… [read post]
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]
21 May 2015, 4:29 am
Last year, a federal jury in Louisiana ordered Takeda and Eli Lilly & Co., which partnered with Takeda to sell Actos in the US, to pay a combined $9 billion judgment to a plaintiff who claimed that Actos caused his bladder cancer. [read post]
19 Oct 2007, 5:14 am
According to an October 17, 2007 article, "FDA Says Diabetes Drug May Cause Pancreatitis", by Jennifer Corbett Dooren:Byetta is co-marketed by Amylin Pharmaceuticals Inc., based in San Diego, and Eli Lilly & Co., of Indianapolis. [read post]
6 May 2014, 7:45 am
Eli Lilly & Co., 119 F.3d 1559 (Fed. [read post]
15 Sep 2010, 2:40 am
(Afro-IP) Africa: Giving consumers power in the battle against counterfeits (Afro-IP) Australia: Review Four Corners’ ‘Body Corporate’ program on gene patenting (Patentology) India: Roche and Novartis, finally, manage to defend their patents in oppositions filed by Cipla (Spicy IP) South Africa: San people push for new legislation – demand protection for indigenous knowledge and IP including medicinal remedies derived from plants including Hoodia (Afro-IP) US: PHOSITA:… [read post]
10 Aug 2010, 8:44 pm
General Coverage of anti-counterfeit policy debate varies widely across global media (IP Watch) WHO declares flu pandemic over; experts behind response to be revealed (IP Watch) Australia: TGA to implement alert system for new ARTG registrations (IP Whiteboard) EU: Final petition of the Advocate-General / Jodosulfuron- SPC for plant protection products (EPLAW) India: Parliamentary Committee on Health tables report on issues relating to availability of generic medicines (Spicy IP) Peru:… [read post]
3 Feb 2009, 3:22 pm
Darvon has been on the market since 1957, and was developed by Eli Lilly & Co. [read post]
